{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:33:55Z","timestamp":1789256035669,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100013981","name":"American Academy of Sleep Medicine Foundation","doi-asserted-by":"publisher","award":["191-SR-18"],"award-info":[{"award-number":["191-SR-18"]}],"id":[{"id":"10.13039\/100013981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS111280"],"award-info":[{"award-number":["R01 NS111280"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s40263-024-01122-y","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T17:01:52Z","timestamp":1726938112000},"page":"909-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial"],"prefix":"10.1007","volume":"38","clinical-trial-number":[{"clinical-trial-number":"nct03772314","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-6847","authenticated-orcid":false,"given":"Lynn Marie","family":"Trotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surina","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Bliwise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"issue":"7","key":"1122_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neurol.2023.08.001","volume":"179","author":"L Barateau","year":"2023","unstructured":"Barateau L, Pizza F, Chenini S, Peter-Derex L, Dauvilliers Y. Narcolepsies, update in 2023. Rev Neurol (Paris). 2023;179(7):727\u201340. https:\/\/doi.org\/10.1016\/j.neurol.2023.08.001.","journal-title":"Rev Neurol (Paris)."},{"key":"1122_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.sleep.2024.05.013","volume":"119","author":"MJ Thorpy","year":"2024","unstructured":"Thorpy MJ, Krahn L, Ruoff C, Foldvary-Schaefer N. Clinical considerations in the treatment of idiopathic hypersomnia. Sleep Med. 2024;119:488\u201398. https:\/\/doi.org\/10.1016\/j.sleep.2024.05.013.","journal-title":"Sleep Med"},{"issue":"9","key":"1122_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.5664\/jcsm.9326","volume":"17","author":"K Maski","year":"2021","unstructured":"Maski K, Trotti LM, Kotagal S, Auger RR, Swick TJ, Rowley JA, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021;17(9):1895\u2013945. https:\/\/doi.org\/10.5664\/jcsm.9326.","journal-title":"J Clin Sleep Med"},{"key":"1122_CR4","doi-asserted-by":"publisher","unstructured":"Trotti LM, Becker LA, Friederich Murray C, Hoque R. Medications for daytime sleepiness in individuals with idiopathic hypersomnia. Cochrane Database Syst Rev. 2021;5:CD012714. https:\/\/doi.org\/10.1002\/14651858.CD012714.pub2.","DOI":"10.1002\/14651858.CD012714.pub2"},{"key":"1122_CR5","doi-asserted-by":"publisher","unstructured":"Maski K, Trotti LM, Kotagal S, Auger RR, Rowley JA, D. HS, et al. Treatment of Central Disorders of Hypersomnolence: An American Academy of Sleep Medicine Clinical Practice Guideline Journal of Clinical Sleep Medicine. 2021;17(9):1881-93. https:\/\/doi.org\/10.5664\/jcsm.9328.","DOI":"10.5664\/jcsm.9328"},{"key":"1122_CR6","doi-asserted-by":"publisher","unstructured":"Chien PY, Kuo CY, Lin MH, Chang YJ, Hung CC. Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis. J Clin Med. 2022;11(21). https:\/\/doi.org\/10.3390\/jcm11216302.","DOI":"10.3390\/jcm11216302"},{"key":"1122_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/NSS.S404113","volume":"15","author":"S Zhan","year":"2023","unstructured":"Zhan S, Ye H, Li N, Zhang Y, Cheng Y, Wang Y, et al. Comparative efficacy and safety of multiple wake-promoting agents for the treatment of excessive daytime sleepiness in narcolepsy: a network meta-analysis. Nat Sci Sleep. 2023;15:217\u201330. https:\/\/doi.org\/10.2147\/NSS.S404113.","journal-title":"Nat Sci Sleep."},{"key":"1122_CR8","unstructured":"Derogatis LR. Symptom Checklist-90-R: Administration, Scoring, and Procedures Manual. Bloomington, IN: NCS Pearson; 1994."},{"key":"1122_CR9","unstructured":"International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014."},{"key":"1122_CR10","unstructured":"Urbaniak GC, Plous S. Research Randomizer (Version 4.0) [Computer software]."},{"key":"1122_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112547","volume":"281","author":"KA Kaplan","year":"2019","unstructured":"Kaplan KA, Plante DT, Cook JD, Harvey AG. Development and validation of the Hypersomnia Severity Index (HSI): a measure to assess hypersomnia severity and impairment in psychiatric disorders. Psychiatry Res. 2019;281: 112547. https:\/\/doi.org\/10.1016\/j.psychres.2019.112547.","journal-title":"Psychiatry Res"},{"issue":"5","key":"1122_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10608-015-9686-4","volume":"39","author":"JC Kanady","year":"2015","unstructured":"Kanady JC, Harvey AG. Development and validation of the sleep inertia questionnaire (SIQ) and assessment of sleep inertia in analogue and clinical depression. Cogn Ther Res. 2015;39(5):601\u201312. https:\/\/doi.org\/10.1007\/s10608-015-9686-4.","journal-title":"Cogn Ther Res"},{"key":"1122_CR13","doi-asserted-by":"crossref","unstructured":"Guy W. ECDEU assessment manual for psychopharmacology (DHEW Publication No. ADM 76-338). Washington, D.C.: U.S. Governmenta Printing Office; 1976 1976.","DOI":"10.1037\/e591322011-001"},{"issue":"7","key":"1122_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4065\/mcp.2009.0778","volume":"85","author":"RP Rosenberg","year":"2010","unstructured":"Rosenberg RP, Bogan RK, Tiller JM, Yang R, Youakim JM, Earl CQ, et al. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc. 2010;85(7):630\u20138. https:\/\/doi.org\/10.4065\/mcp.2009.0778.","journal-title":"Mayo Clin Proc"},{"key":"1122_CR15","doi-asserted-by":"publisher","unstructured":"Liu GJ, Wu L, Lin Wang S, Xu LL, Ying Chang L, Fu Wang Y. Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Clinical therapeutics. 2016;38(1):162-79 e6. https:\/\/doi.org\/10.1016\/j.clinthera.2015.10.010.","DOI":"10.1016\/j.clinthera.2015.10.010"},{"key":"1122_CR16","doi-asserted-by":"publisher","unstructured":"Scrima L, Emsellem HA, Becker PM, Ruoff C, Lankford A, Bream G, et al. Identifying Clinically Important Difference on the Epworth Sleepiness Scale: Results from a Narcolepsy Clinical Trial of JZP-110. Sleep Medicine. 2017;epub ahead of print. https:\/\/doi.org\/10.1016\/j.sleep.2017.07.006.","DOI":"10.1016\/j.sleep.2017.07.006"},{"issue":"5","key":"1122_CR17","doi-asserted-by":"publisher","first-page":"E194","DOI":"10.1503\/cmaj.151104","volume":"189","author":"E Maund","year":"2017","unstructured":"Maund E, Guski LS, Gotzsche PC. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ. 2017;189(5):E194\u2013203. https:\/\/doi.org\/10.1503\/cmaj.151104.","journal-title":"CMAJ"},{"key":"1122_CR18","doi-asserted-by":"publisher","unstructured":"Wiffen PJ, Derry S, Bell RF, Rice AS, Tolle TR, Phillips T, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD007938. https:\/\/doi.org\/10.1002\/14651858.CD007938.pub4.","DOI":"10.1002\/14651858.CD007938.pub4"},{"issue":"3","key":"1122_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315\u201325.","journal-title":"J Psychosom Res"},{"issue":"1\u20132","key":"1122_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jns.2013.05.023","volume":"331","author":"YC Learmonth","year":"2013","unstructured":"Learmonth YC, Dlugonski D, Pilutti LA, Sandroff BM, Klaren R, Motl RW. Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale. J Neurol Sci. 2013;331(1\u20132):102\u20137. https:\/\/doi.org\/10.1016\/j.jns.2013.05.023.","journal-title":"J Neurol Sci"},{"issue":"2","key":"1122_CR21","first-page":"97","volume":"4","author":"JA Horne","year":"1976","unstructured":"Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97\u2013110.","journal-title":"Int J Chronobiol"},{"issue":"10","key":"1122_CR22","first-page":"835","volume":"20","author":"TE Weaver","year":"1997","unstructured":"Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20(10):835\u201343.","journal-title":"Sleep"},{"issue":"11","key":"1122_CR23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","volume":"12","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. The Lancet Neurology. 2013;12(11):1068\u201375.","journal-title":"The Lancet Neurology."},{"key":"1122_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.sleep.2021.06.008","volume":"84","author":"MM Ohayon","year":"2021","unstructured":"Ohayon MM, Thorpy MJ, Carls G, Black J, Cisternas M, Pasta DJ, et al. The Nexus Narcolepsy Registry: methodology, study population characteristics, and patterns and predictors of narcolepsy diagnosis. Sleep Med. 2021;84:405\u201314. https:\/\/doi.org\/10.1016\/j.sleep.2021.06.008.","journal-title":"Sleep Med"},{"key":"1122_CR25","unstructured":"The Voice of the Patient: Narcolepsy. 2014."},{"key":"1122_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.sleep.2020.08.034","volume":"75","author":"LM Trotti","year":"2020","unstructured":"Trotti LM, Ong JC, Plante DT, Friederich Murray C, King R, Bliwise DL. Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry. Sleep Med. 2020;75:343\u20139. https:\/\/doi.org\/10.1016\/j.sleep.2020.08.034.","journal-title":"Sleep Med"},{"key":"1122_CR27","unstructured":"International Classification of Sleep Disorders, 3rd edition, text revision (ICSD-3-TR). Darien, IL: American Academy of Sleep Medicine; 2023."},{"key":"1122_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsad323","author":"L Barateau","year":"2024","unstructured":"Barateau L, Chenini S, Denis C, Lorber Q, Beziat S, Jaussent I, et al. Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2. Sleep. 2024. https:\/\/doi.org\/10.1093\/sleep\/zsad323.","journal-title":"Sleep"},{"key":"1122_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.08.005","author":"LM Trotti","year":"2016","unstructured":"Trotti LM. Waking up is the hardest thing I do all day: Sleep inertia and sleep drunkenness. Sleep Med Rev. 2016. https:\/\/doi.org\/10.1016\/j.smrv.2016.08.005.","journal-title":"Sleep Med Rev"},{"issue":"15","key":"1122_CR30","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1212\/WNL.0000000000007264","volume":"92","author":"Y Dauvilliers","year":"2019","unstructured":"Dauvilliers Y, Evangelista E, Barateau L, Lopez R, Chenini S, Delbos C, et al. Measurement of symptoms in idiopathic hypersomnia: The Idiopathic Hypersomnia Severity Scale. Neurology. 2019;92(15):e1754\u201362. https:\/\/doi.org\/10.1212\/WNL.0000000000007264.","journal-title":"Neurology"},{"key":"1122_CR31","doi-asserted-by":"publisher","unstructured":"Evangelista E, Rassu AL, Lopez R, Biagioli N, Chenini S, Barateau L, et al. Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia. Sleep. 2022;45(1). https:\/\/doi.org\/10.1093\/sleep\/zsab220.","DOI":"10.1093\/sleep\/zsab220"},{"issue":"5","key":"1122_CR32","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.5664\/jcsm.9884","volume":"18","author":"LM Trotti","year":"2022","unstructured":"Trotti LM, Saini P, Bremer E, Mariano C, Moron D, Rye DB, et al. The Psychomotor Vigilance Test as a measure of alertness and sleep inertia in people with central disorders of hypersomnolence. J Clin Sleep Med. 2022;18(5):1395\u2013403. https:\/\/doi.org\/10.5664\/jcsm.9884.","journal-title":"J Clin Sleep Med"},{"key":"1122_CR33","doi-asserted-by":"crossref","unstructured":"Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Sonka K, Thorpy MJ, et al. Efficacy and Safety of Lower-Sodium Oxybate in Adults With Idiopathic Hypersomnia: A Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study. Lancet Neurol. 2022.","DOI":"10.1016\/S1474-4422(21)00368-9"},{"issue":"1","key":"1122_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jsr.12201","volume":"24","author":"G Mayer","year":"2015","unstructured":"Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A. Modafinil in the treatment of idiopathic hypersomnia without long sleep time-a randomized, double-blind, placebo-controlled study. J Sleep Res. 2015;24(1):74\u201381. https:\/\/doi.org\/10.1111\/jsr.12201.","journal-title":"J Sleep Res"},{"key":"1122_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.sleep.2021.01.018","volume":"80","author":"Y Inoue","year":"2021","unstructured":"Inoue Y, Tabata T, Tsukimori N. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Med. 2021;80:315\u201321. https:\/\/doi.org\/10.1016\/j.sleep.2021.01.018.","journal-title":"Sleep Med"},{"key":"1122_CR36","doi-asserted-by":"publisher","unstructured":"Sonka K, Susta M, M. B. Narcolepsy with and without cataplexy, idiopathc hypersomnia with and without long sleep time: a cluster analysis. Sleep Medicine. 2015;epub ahead of print. https:\/\/doi.org\/10.1016\/j.sleep.2014.09.016.","DOI":"10.1016\/j.sleep.2014.09.016"},{"issue":"8","key":"1122_CR37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.5664\/jcsm.2922","volume":"9","author":"LM Trotti","year":"2013","unstructured":"Trotti LM, Staab BA, Rye DB. Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. J Clin Sleep Med. 2013;9(8):789\u201395. https:\/\/doi.org\/10.5664\/jcsm.2922.","journal-title":"J Clin Sleep Med"},{"key":"1122_CR38","doi-asserted-by":"crossref","unstructured":"Ruoff C, Pizza F, Trotti LM, Sonka K, Vandi S, Cheung J, et al. The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study. J Clin Sleep Med. 2017.","DOI":"10.5664\/jcsm.6882"},{"key":"1122_CR39","doi-asserted-by":"publisher","unstructured":"Lopez R, Doukkali A, Barateau L, Evangelista E, Chenini S, Jaussent I, et al. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence. Sleep. 2017;40(12). https:\/\/doi.org\/10.1093\/sleep\/zsx164.","DOI":"10.1093\/sleep\/zsx164"},{"key":"1122_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa044","author":"R Fronczek","year":"2020","unstructured":"Fronczek R, Arnulf I, Baumann CR, Maski K, Pizza F, Trotti LM. To Split or to Lump? Classifying the Central Disorders of Hypersomnolence. Sleep. 2020. https:\/\/doi.org\/10.1093\/sleep\/zsaa044.","journal-title":"Sleep"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01122-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T12:19:42Z","timestamp":1729167582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01122-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01122-y","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"22 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research project was made possible by an award from the American Academy of Sleep Medicine Foundation, a foundation of the American Academy of Sleep Medicine. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors, and do not necessarily reflect the views of the American Academy of Sleep Medicine Foundation. This work was additionally supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378 (statistical consultation) and the National Institutes of Neurological Disorders and Stroke (R01 NS111280 to LMT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"LM Trotti is a member of the Board of Directors of the American Academy of Sleep Medicine, the American Academy of Sleep Medicine Foundation, and the American Board of Sleep Medicine; funds for this work were awarded by the Foundation prior to Dr. Trotti\u2019s joining of these boards. DB Rye reports consulting fees from Jazz and Takeda, who have or are developing treatments for idiopathic hypersomnia and\/or narcolepsy type 2. The other authors have no conflicts to report relevant to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"This protocol (IRB00108167) was approved by Emory University\u2019s Institutional Review Board and performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants provided written informed consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"N\/A.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"N\/A.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"(1) Conception and design of the study (LMT, DBR, DLB); (2) acquisition or analysis of Data (all authors); (3) drafting the manuscript (LMT); (4) reviewing the manuscript for important intellectual content (all authors). All authors have read and approve the final version of the manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}